PAR-23-145 - Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 2
Active NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|---|---|---|---|---|
Notice of Special Interest (NOSI): Quantum Sensing Technologies in Biomedical Applications | NOT-EB-23-022 | NIBIB , NCATS , NCI , NEI , NHLBI , NIGMS | Dec 13, 2023 | Jan 27, 2027 | R35, RM1, R21, R01, U01, R15, R13, K99/R00 |
Expired NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|---|---|---|---|---|
Notice of Special Interest (NOSI): Inclusion of Economic Factors and Outcomes in Infectious Disease Modeling Studies | NOT-GM-22-021 | NIGMS | Feb 1, 2022 | Jan 8, 2025 | RM1, R35, R01, K99/R00, K25, K08, F30, K23, F33, R15, F32, F31 |